CA Clover

CCI Approves Acquisition of Piramal Pharma's 20% Stakes Acquisition by CA Clover Intermediate

CCI approves proposed combination involving the acquisition of 20% of the issued and paid-up equity share capital of Piramal Pharma Limited (Pharma Co.) by CA Clover Intermediate II Investments (Curie).